Industry Symposia

Industry Symposia Schedule

We welcome delegates to discover our industry program below spread over Friday, March 31 and Saturday, April 1. These 16 sessions, delivering the latest advancements in global kidney care, are scheduled at either 1p.m or 5p.m. Whether you catch the sessions in Bangkok, during the live stream or later with on-demand viewing, these sessions are included in your full congress registration.

Watch online for free! The online viewing (live stream and on-demand) of industry symposia are completely open-access without any fees. Check out our virtual Open-Access registration. Pre-registration is still required. In-person attendees must be fully registered to enter room.

  • SGLT2 inhibitors: A driving force to improved standard-of-care in CKD
  • Organized by Science Collected. Supported by an unrestricted educational grant from AstraZeneca
  • 13:00 – 14:00 | Room – MR109 (CDHG)

  • Evolving Landscape in IgA Nephropathy Patient Management
  • Organized by Calliditas Therapeutics
  • 13:00 – 14:00 | Room – PL1

  • Chinook Therapeutics: Changing the Course of Kidney Care
  • Organized by Chinook Therapeutics
  • 13:00 – 14:00 | Room – MR110

  • C3G and IC-MPGN: Current state of evidence and how to tackle challenges in clinical management
  • Organized by Novartis
  • 13:00 – 14:00 | Room – MR111

  • The Evolving Treatment Landscape in IgA Nephropathy: A Case-Based Discussion
  • Organized by Travere Therapeutics
  • 13:00 – 14:00 | Room – MR109 (ABEF)

  • Optimizing Nutritional Therapy with Ketoanalogues in CKD Patients
  • Organized by Fresenius Kabi
  • 17:00 – 18:00 | Room – MR109 (CDHG)

  • Developments Into Expanding the Understanding of Anemia in CKD
  • Supported by GSK
  • 17:00 – 18:00 | Room – MR111

  • Evidence Based Treatment of Anemia in CKD: Focus on HIF-PHIs
  • Organized by Zydus Lifesciences
  • 17:00 – 18:00 | Room – MR109 (ABEF)

  • Atypical hemolytic uremic syndrome: closing the diagnosis-treatment gap
  • Organized by Alexion AstraZeneca Rare Disease
  • 13:00 – 14:00 | Room – MR109 (CDHG)

  • Optimising COVID-19 Prevention for Nephrology Patients: Leaving No Patient Behind
  • Organized by AstraZeneca
  • 13:00 – 14:00 | Room – BR 1

  • Non-steroidal MRAs: A new treatment pillar for chronic kidney disease in type 2 diabetes
  • Organized by Bayer
  • 13:00 – 14:00 | Room – MR109 (ABEF)

  • Looking Beyond Glycemic Control: Cardio Renal and Metabolic Benefits of SGLT2i
  • Organized by Boehringer Ingelheim
  • 13:00 – 14:00 | Room – PL1

  • Understanding the role of complement in IgA nephropathy: Key to unlocking new treatment approaches
  • Organized by Novartis
  • 13:00 – 14:00 | Room – MR110

  • Emerging Therapies in IgA Nephropathy: The Rationale for Targeting APRIL
  • Organized by Otsuka Visterra
  • 13:00 – 14:00 | Room – MR111

Package

➡ Live 45–60-minute session in the congress venue

➡ Session streamed live to online audience around the world

➡ Session recorded and available online post-congress (Open-access / No paid registration required)

➡ Theater set-up with stage, lectern and speaker table(s)

➡ Standard AV equipment and technician support

➡ Ability to stream in virtual speakers to live session for presentation and Q&A

➡ Advertisement of program displayed on congress website in symposia e-book (A4-sized design provided by sponsor) E-book separated from scientific program

➡ Opportunity to use digital signage in exhibition hall (Design provided by sponsor)

➡ Five (5) industry passes to access symposia

Scheduling and Fees

MR 111 ABC
Capacity: 360*
MR 110 ABC
Capacity: 360*
MR 109 CD HG
Capacity: 360*
MR 109 AB EF
Capacity: 360*
BR 1
Capacity: 600*
PL 1
Capacity: 600*
07:30 – 08:15 Available
Reference: Slot #1
Available
Reference: Slot #2
Available
Reference: Slot #3
Available
Reference: Slot #4
08:30 – 10:00 Session
10:00 – 10:30 Coffee Break
10:30 – 11:30 Plenary
11:45 – 12:45 Session
13:00 – 14:00  

 

chinook

astrazeneca  

 

Baxter logo

 

calliditas logo

14:15 – 16:45 Session
16:00 – 17:00 Moderated Poster Session
17:00 – 18:00 Available
Reference: Slot #25
MR 111 ABC
Capacity: 360*
MR 110 ABC
Capacity: 360*
MR 109 CD HG
Capacity: 360*
MR 109 AB EF
Capacity: 360*
BR 1
Capacity: 600*
PL 1
Capacity: 600*
07:30 – 08:15 Available
Reference: Slot #11
Available
Reference: Slot #12
Available
Reference: Slot #13
Available
Reference: Slot #14
08:30 – 10:00 Session
10:00 – 10:30 Coffee Break
10:30 – 11:30 Plenary
11:45 – 12:45 Session
13:00 – 14:00  

otsuka-visterra logo

 

 

alexion logo

astrazeneca
14:15 – 16:45 Session
16:00 – 17:00 Moderated Poster Session
17:00 – 18:00 Available
Reference: Slot #28
 

BI & Lilly logo

Available
Reference: Slot #30
Available
Reference: Slot #31
MR 111 ABC
Capacity: 360*
MR 110 ABC
Capacity: 360*
MR 109 CD HG
Capacity: 360*
MR 109 AB EF
Capacity: 360*
BR 1
Capacity: 600*
PL 1
Capacity: 600*
07:30 – 08:15 Available
Reference: Slot #21
Available
Reference: Slot #22
Available
Reference: Slot #23
08:30 – 10:00 Session
10:00 – 10:30 Coffee Break
10:30 – 11:30 Plenary
11:45 – 12:45 Session

*Based on the rooms to be built in venue. Final capacity may slightly change.

Not included in fee:

(1) Optional catering orders (i.e. lunch boxes)

(2) Travel, accommodation or registration of industry symposia faculty

(3) Rehearsal slot (can be purchased for $1,000)

Program

Industry session content must be reviewed and approved by the WCN Congress Organizing Committee (COC) who will ascertain the scientific value of the program. Sponsors will be notified of any need for revisions, which must be taken into consideration. All modifications must be approved. The symposium will be added to the WCN’23 website once the COC has approved and full payment has been received.